SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-18-015315
Filing Date
2018-11-09
Accepted
2018-11-09 17:01:24
Documents
46
Period of Report
2018-09-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0918_actiniumpharma.htm 10-Q 594162
2 AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA f10q0918ex4-1_actinium.htm EX-4.1 5424
3 AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA f10q0918ex4-2_actinium.htm EX-4.2 5128
4 AMENDMENT TO ACTINIUM PHARMACEUTICALS, INC. WARRANT TO PURCHASE COMMON STOCK, DA f10q0918ex4-3_actinium.htm EX-4.3 4850
5 CERTIFICATION f10q0918ex31-1_actinium.htm EX-31.1 10766
6 CERTIFICATION f10q0918ex31-2_actinium.htm EX-31.2 10767
7 CERTIFICATION f10q0918ex32-1_actinium.htm EX-32.1 4586
8 CERTIFICATION f10q0918ex32-2_actinium.htm EX-32.2 4566
  Complete submission text file 0001213900-18-015315.txt   2535635

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE FILE atnm-20180930.xml EX-101.INS 323275
10 XBRL SCHEMA FILE atnm-20180930.xsd EX-101.SCH 31052
11 XBRL CALCULATION FILE atnm-20180930_cal.xml EX-101.CAL 30374
12 XBRL DEFINITION FILE atnm-20180930_def.xml EX-101.DEF 138912
13 XBRL LABEL FILE atnm-20180930_lab.xml EX-101.LAB 233989
14 XBRL PRESENTATION FILE atnm-20180930_pre.xml EX-101.PRE 195894
Mailing Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016
Business Address 275 MADISON AVENUE, 7TH FLOOR NEW YORK NY 10016 646-677-3875
Actinium Pharmaceuticals, Inc. (Filer) CIK: 0001388320 (see all company filings)

IRS No.: 880378336 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36374 | Film No.: 181173837
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1